Results 171 to 180 of about 523,743 (349)
This study uses single‐nucleus RNA sequencing and spatial transcriptomics to investigate penile squamous cell carcinoma (PSCC). It reveals that PSCC tumor cells mimic normal penile epithelium differentiation, independent of HPV status. The Tum_1 subtype shows basal stem‐like characteristics and promotes invasiveness. HPV‐positive basal stem‐like tumors
Hongjian Song+37 more
wiley +1 more source
Qianzi Ma,1,2 Nan Wang,3 Xingyue Zheng,1 Junjie Liu,1 Yanlu Che,4 Jingting Wang2 1Department of Otorhinolaryngology-Head and Neck Surgery, The Second Affiliated Hospital, Harbin Medical University, Harbin, People’s Republic of China; 2Department of ...
Ma Q+5 more
doaj
This study reveals that Testosterone–Androgen Receptor signaling delays elderly male bone destruction by upregulation of the osteoblastic extracellular tenascin‐C (TNC). The osteoprotective effect of fibrinogen C‐terminus of TNC is demonstrated in male osteoporotic mice model that osteoblast‐specific Ar‐knockout, potentially via inhibition of ...
Yong Xie+8 more
wiley +1 more source
Augmented Reality Navigation in Craniomaxillofacial/Head and Neck Surgery. [PDF]
Strong EB+18 more
europepmc +1 more source
Surgery in elderly patients with head and neck cancer.
Akio Yoshida, Ken Okamoto, Ryuji Nagano
openalex +2 more sources
Peptide‐Based Biomaterials as a Promising Tool for Cancer Radiotherapy
This review provides a systematic overview of peptide‐based biomaterials in tumor radiotherapy, covering their roles as both radiosensitizers and radiopharmaceuticals. Peptide‐based radiosensitizers are generally divided into three categories: peptides as direct radiosensitizers, peptides as carriers of radiosensitizers, and targeted‐peptide‐modified ...
Qian Wang, Xinhui Chu, Jianfeng Liu
wiley +1 more source
Quantifying capacity of otolaryngology-head and neck surgery in Zimbabwe. [PDF]
Green KJ+8 more
europepmc +1 more source
Avoiding Transfusion in Head and Neck Surgery: Feasibility Study of Erythropoietin [PDF]
Erich M. Sturgis+3 more
openalex +1 more source
Novel ATR/PARP1 dual inhibitors are developed for the first time. Advanced lead B8 effectively reduces cell viability in vitro and suppresses tumor growth in vivo, with better potency than ATRi and PARPi alone or in combination. Mechanistically, B8 induces apoptosis, arrests the cell cycle, and inhibits cancer cells colony formation, migration, and ...
Yuan Gao+13 more
wiley +1 more source